Category: Special Subpopulations

All Podcast Categories
S4-4.4 - NASH-TAG 2023: Emerging Optimism from a Watershed Moment

S4-4.4 – NASH-TAG 2023: Emerging Optimism from a Watershed Moment

This week’s conversation series continues on the theme of reviewing NASH-TAG 2023, a watershed moment for Fatty Liver disease. For this wrap-up feature, Amy Articolo and Naim Alkhouri join Jörn Schattenberg and Roger Green to illustrate their enthusiasm coming out of the conference.

S3-E63 - 2022 NAFLD Year-in-Review Interview Series, Part 3

S3-E63 – 2022 NAFLD Year-in-Review Interview Series, Part 3

Surfing the NASH Tsunami hosts its annual NAFLD Year-in-Review over the second half of December. For the final installment of this Season 3 finale, Surfers Jörn Schattenberg, Louise Campbell and Roger Green interview Naim Alkhouri, Stephen Harrison and Ian Rowe to discuss putting a dent in Fatty Liver disease in 2022 and beyond.

S3-E62 - 2022 NAFLD Year-in-Review Interview Series, Part 2

S3-E62 – 2022 NAFLD Year-in-Review Interview Series, Part 2

Surfing the NASH Tsunami hosts its annual NAFLD Year-in-Review over the second half of December. For the second installment of this Season 3 finale, Surfers Jörn Schattenberg, Louise Campbell and Roger Green interview Mazen Noureddin, Ken Cusi and Jeff Lazarus to discuss putting a dent in Fatty Liver disease in 2022 and beyond.

S3-E59.3 - Year-End Interview with Donna Cryer

S3-E59.3 – Year-End Interview with Donna Cryer

Surfing the NASH Tsunami hosts its Season 3 finale to celebrate a momentous year in Fatty Liver through a series of interviews with Key Opinion Leaders. In this installment, Surfers Jörn Schattenberg, Louise Campbell and Roger Green are joined by Donna Cryer to discuss GLI’s preparations for a promising 2023, promoting patient perspectives, liver health awareness and much more.

S3-E57.4 - Discussing Critical Success Factors for Placebo Cohorts

S3-E57.4 – Discussing Critical Success Factors for Placebo Cohorts

In discussing the Liver Forum, Executive Director Veronica Miller joins guest Manal Abdelmalek, co-host Jörn Schattenberg and Roger Green to investigate how to study efficacy and safety in real time, using collective knowledge and experience with therapies for advancing liver disease. In this final conversation, Veronica, Manal and Jörn each provide their unique perspectives on critical success factors for placebo cohorts.

S3-E56.4 - Integrated Solutions for Improved Patient Support

S3-E56.4 – Integrated Solutions for Improved Patient Support

Surfing the NASH Tsunami hosts its first episode dedicated to nutrition and NASH with distinguished guest, Prof. Shira Zelber-Sagi. In this conversation, she joins Ken Cusi, Jörn Schattenberg, Louise Campbell and Roger Green to discuss integrated solutions to provide more information and better support to patients.

Experience Nudge Learning! Interested in a new way of learning?